Maman Ibrahim Mahaman
PulseAugur coverage of Maman Ibrahim Mahaman — every cluster mentioning Maman Ibrahim Mahaman across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
Quantum risk should be integrated into existing controls, not managed by separate programs
Organizations should approach quantum risk not by launching dedicated programs, but by integrating it into existing control frameworks. The author suggests a six-score system—governance, risk, operational, third-party, …
-
AI automates data tasks, elevating analysts to decision-makers
The role of data analysts is evolving as AI automates routine tasks like data organization, pattern spotting, and report generation. This shift allows analysts to focus on higher-level contributions such as providing bu…
-
GenAI audit gap highlights risks of convincing but unprovable AI outputs
Generative AI systems present a significant audit challenge due to their ability to produce convincing yet inaccurate or biased outputs, a phenomenon termed the 'GenAI audit gap.' This gap arises from the inherent natur…
-
Risk quantification requires common taxonomy before calculation, says expert
Effective risk quantification hinges on establishing a common taxonomy before applying mathematical models, according to Maman Ibrahim. Without a shared language and definitions for risks, different business units may m…
-
Post-Quantum Cryptography Readiness: Organizations Face Major Blind Spots
Organizations are facing significant challenges in preparing for post-quantum cryptography (PQC) migration, with many still employing manual, time-consuming methods rather than strategic approaches. Key blind spots incl…
-
Quantum Risk Demands Enterprise-Wide Decision-Making, Not Just Cybersecurity
Quantum computing poses a significant risk that is often miscategorized as purely a cybersecurity problem. Instead, it represents a broader decision-making challenge that spans across various enterprise functions, inclu…
-
Pharma companies misclassify third-party risks, executive says
A cyber and digital risk executive argues that pharmaceutical companies often misclassify third-party risk events. Instead of logging incidents under the function that absorbed the impact, such as cyber or regulatory, t…
-
Pharma boards confuse scenario models with risk measurements
Boards in the pharmaceutical industry are misinterpreting scenario models as concrete risk measurements, leading to confusion and potentially flawed decision-making. A £312 million figure, representing a modeled future …